NO20012995L - Forbindelser nyttige for behandling av inflammatoriske sykdommer - Google Patents
Forbindelser nyttige for behandling av inflammatoriske sykdommerInfo
- Publication number
- NO20012995L NO20012995L NO20012995A NO20012995A NO20012995L NO 20012995 L NO20012995 L NO 20012995L NO 20012995 A NO20012995 A NO 20012995A NO 20012995 A NO20012995 A NO 20012995A NO 20012995 L NO20012995 L NO 20012995L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- inflammatory diseases
- compounds useful
- compounds
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9828074.6A GB9828074D0 (en) | 1998-12-18 | 1998-12-18 | Therapeutically useful compounds |
PCT/EP1999/010000 WO2000037444A1 (fr) | 1998-12-18 | 1999-12-16 | Composes utilises dans le traitement de maladies inflammatoires |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20012995D0 NO20012995D0 (no) | 2001-06-15 |
NO20012995L true NO20012995L (no) | 2001-08-15 |
Family
ID=10844608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012995A NO20012995L (no) | 1998-12-18 | 2001-06-15 | Forbindelser nyttige for behandling av inflammatoriske sykdommer |
Country Status (26)
Country | Link |
---|---|
US (1) | US6867192B1 (fr) |
EP (1) | EP1140837B1 (fr) |
JP (1) | JP4431282B2 (fr) |
KR (1) | KR20010101258A (fr) |
CN (1) | CN1330637A (fr) |
AR (1) | AR023727A1 (fr) |
AT (1) | ATE273954T1 (fr) |
AU (1) | AU760169B2 (fr) |
BR (1) | BR9916282A (fr) |
CA (1) | CA2355630A1 (fr) |
CO (1) | CO5170533A1 (fr) |
CZ (1) | CZ20012209A3 (fr) |
DE (1) | DE69919580T2 (fr) |
ES (1) | ES2226488T3 (fr) |
GB (1) | GB9828074D0 (fr) |
GT (1) | GT199900217A (fr) |
HK (1) | HK1038744A1 (fr) |
HU (1) | HUP0104867A3 (fr) |
IL (1) | IL142908A0 (fr) |
NO (1) | NO20012995L (fr) |
NZ (1) | NZ511478A (fr) |
PE (1) | PE20001387A1 (fr) |
PL (1) | PL348059A1 (fr) |
TR (1) | TR200101709T2 (fr) |
WO (1) | WO2000037444A1 (fr) |
ZA (1) | ZA200103948B (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0016818A (pt) | 1999-12-28 | 2002-10-01 | Pfizer Prod Inc | Inibidores não-peptidila de adesão celular dependente de vla-4 úteis no tratamento de doenças inflamatórias, auto-imunes e respiratórias |
GB0014892D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
GB0014883D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
GB0014869D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
GB0014881D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
GB0014849D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Pharmaceutical aerosol formulation |
GB0014851D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
GB0014947D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
GB0127423D0 (en) * | 2001-11-15 | 2002-01-09 | Glaxo Group Ltd | Process |
GB0218630D0 (en) | 2002-08-10 | 2002-09-18 | Tanabe Seiyaku Co | Novel compounds |
AU2004240940A1 (en) | 2003-05-20 | 2004-12-02 | Genentech, Inc. | Thiocarbamate inhibitors of alpha-4 integrins |
AU2005249566B2 (en) | 2004-06-04 | 2010-11-11 | Genentech, Inc. | Method for treating multiple sclerosis |
US8159428B2 (en) | 2005-02-23 | 2012-04-17 | Pixtronix, Inc. | Display methods and apparatus |
US9229222B2 (en) | 2005-02-23 | 2016-01-05 | Pixtronix, Inc. | Alignment methods in fluid-filled MEMS displays |
US20070205969A1 (en) | 2005-02-23 | 2007-09-06 | Pixtronix, Incorporated | Direct-view MEMS display devices and methods for generating images thereon |
US8519945B2 (en) | 2006-01-06 | 2013-08-27 | Pixtronix, Inc. | Circuits for controlling display apparatus |
US9082353B2 (en) | 2010-01-05 | 2015-07-14 | Pixtronix, Inc. | Circuits for controlling display apparatus |
US7742016B2 (en) | 2005-02-23 | 2010-06-22 | Pixtronix, Incorporated | Display methods and apparatus |
US9087486B2 (en) | 2005-02-23 | 2015-07-21 | Pixtronix, Inc. | Circuits for controlling display apparatus |
US7999994B2 (en) | 2005-02-23 | 2011-08-16 | Pixtronix, Inc. | Display apparatus and methods for manufacture thereof |
US8482496B2 (en) | 2006-01-06 | 2013-07-09 | Pixtronix, Inc. | Circuits for controlling MEMS display apparatus on a transparent substrate |
US9158106B2 (en) | 2005-02-23 | 2015-10-13 | Pixtronix, Inc. | Display methods and apparatus |
US9261694B2 (en) | 2005-02-23 | 2016-02-16 | Pixtronix, Inc. | Display apparatus and methods for manufacture thereof |
US8310442B2 (en) | 2005-02-23 | 2012-11-13 | Pixtronix, Inc. | Circuits for controlling display apparatus |
MY149159A (en) | 2005-11-15 | 2013-07-31 | Hoffmann La Roche | Method for treating joint damage |
US8526096B2 (en) | 2006-02-23 | 2013-09-03 | Pixtronix, Inc. | Mechanical light modulators with stressed beams |
US9176318B2 (en) * | 2007-05-18 | 2015-11-03 | Pixtronix, Inc. | Methods for manufacturing fluid-filled MEMS displays |
TW201014605A (en) | 2008-09-16 | 2010-04-16 | Genentech Inc | Methods for treating progressive multiple sclerosis |
US8169679B2 (en) | 2008-10-27 | 2012-05-01 | Pixtronix, Inc. | MEMS anchors |
WO2010075249A2 (fr) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | Méthode de traitement de la polyarthrite rhumatoïde avec des antagonistes de cellules b |
WO2011097252A2 (fr) | 2010-02-02 | 2011-08-11 | Pixtronix, Inc. | Procédés de fabrication d'un appareil d'affichage rempli de fluide et scellé à froid |
WO2013101771A2 (fr) | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions et méthode pour le traitement de maladies auto-immunes |
TW201334789A (zh) | 2012-01-31 | 2013-09-01 | Genentech Inc | 抗ige抗體及其使用方法 |
US9134552B2 (en) | 2013-03-13 | 2015-09-15 | Pixtronix, Inc. | Display apparatus with narrow gap electrostatic actuators |
BR112016028081A2 (pt) * | 2014-05-30 | 2017-08-22 | Sphaera Pharma Private Ltd | Novos compostos como agentes antituberculares |
TN2017000538A1 (en) * | 2015-07-08 | 2019-04-12 | Axerovision Inc | Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditions |
CN108431038A (zh) | 2015-10-06 | 2018-08-21 | 豪夫迈·罗氏有限公司 | 治疗多发性硬化的方法 |
PL3464336T3 (pl) * | 2016-06-01 | 2022-05-16 | Athira Pharma, Inc. | Związki |
CN109722455B (zh) * | 2017-10-31 | 2022-03-11 | 中国科学院天津工业生物技术研究所 | 微生物发酵生产谷内酯的方法、工程菌及应用 |
EP3810085A1 (fr) | 2018-06-20 | 2021-04-28 | Progenity, Inc. | Traitement d'une maladie du tractus gastro-intestinal par un inhibiteur de l'intégrine |
US11224600B2 (en) | 2018-10-30 | 2022-01-18 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
CA3114240C (fr) | 2018-10-30 | 2023-09-05 | Gilead Sciences, Inc. | Derives d'imidazopyridine utilises en tant qu'inhibiteurs de l'integrine alpha4beta7 |
WO2020092401A1 (fr) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | COMPOSÉS POUR INHIBITION DE L'INTÉGRINE ALPHA 4β7 |
EP3873884A1 (fr) | 2018-10-30 | 2021-09-08 | Gilead Sciences, Inc. | Dérivés de quinoléine utilisés en tant qu'inhibiteurs de l'intégrine alpha4bêta7 |
JP7491996B2 (ja) | 2019-08-14 | 2024-05-28 | ギリアード サイエンシーズ, インコーポレイテッド | α4β7インテグリンの阻害のための化合物 |
JP2023546915A (ja) * | 2020-10-21 | 2023-11-08 | アズーラ オフサルミックス エルティーディー. | 眼障害を処置するための化合物および方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1593858A1 (de) * | 1967-03-02 | 1970-10-29 | Hoechst Ag | Verfahren zur Herstellung tyrosinhaltiger Peptide und deren Derivaten |
US4105602A (en) * | 1975-02-10 | 1978-08-08 | Armour Pharmaceutical Company | Synthesis of peptides with parathyroid hormone activity |
US6248713B1 (en) * | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
EP0998282A4 (fr) | 1997-05-29 | 2000-08-30 | Merck & Co Inc | Sulfamides utilises en tant qu'inhibiteurs de l'adherence cellulaire |
CA2291778A1 (fr) | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Composes d'amide heterocycliques utilises en tant qu'inhibiteurs de l'adhesion cellulaire |
DE69833654T2 (de) * | 1997-05-29 | 2006-12-14 | Merck & Co., Inc. (A New Jersey Corp.) | Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren |
WO1998054207A1 (fr) * | 1997-05-30 | 1998-12-03 | Celltech Therapeutics Limited | Derives anti-inflammatoires de tyrosine |
-
1998
- 1998-12-18 GB GBGB9828074.6A patent/GB9828074D0/en not_active Ceased
-
1999
- 1999-12-15 CO CO99078241A patent/CO5170533A1/es not_active Application Discontinuation
- 1999-12-15 AR ARP990106429A patent/AR023727A1/es not_active Application Discontinuation
- 1999-12-16 HU HU0104867A patent/HUP0104867A3/hu unknown
- 1999-12-16 JP JP2000589516A patent/JP4431282B2/ja not_active Expired - Lifetime
- 1999-12-16 PE PE1999001274A patent/PE20001387A1/es not_active Application Discontinuation
- 1999-12-16 AT AT99964583T patent/ATE273954T1/de not_active IP Right Cessation
- 1999-12-16 NZ NZ511478A patent/NZ511478A/en unknown
- 1999-12-16 AU AU30391/00A patent/AU760169B2/en not_active Ceased
- 1999-12-16 PL PL99348059A patent/PL348059A1/xx not_active Application Discontinuation
- 1999-12-16 BR BR9916282-2A patent/BR9916282A/pt not_active IP Right Cessation
- 1999-12-16 CA CA002355630A patent/CA2355630A1/fr not_active Abandoned
- 1999-12-16 KR KR1020017007579A patent/KR20010101258A/ko not_active Application Discontinuation
- 1999-12-16 TR TR2001/01709T patent/TR200101709T2/xx unknown
- 1999-12-16 US US09/868,395 patent/US6867192B1/en not_active Expired - Lifetime
- 1999-12-16 EP EP99964583A patent/EP1140837B1/fr not_active Expired - Lifetime
- 1999-12-16 ES ES99964583T patent/ES2226488T3/es not_active Expired - Lifetime
- 1999-12-16 CZ CZ20012209A patent/CZ20012209A3/cs unknown
- 1999-12-16 IL IL14290899A patent/IL142908A0/xx unknown
- 1999-12-16 DE DE69919580T patent/DE69919580T2/de not_active Expired - Lifetime
- 1999-12-16 CN CN99814654A patent/CN1330637A/zh active Pending
- 1999-12-16 WO PCT/EP1999/010000 patent/WO2000037444A1/fr not_active Application Discontinuation
- 1999-12-17 GT GT199900217A patent/GT199900217A/es unknown
-
2001
- 2001-05-15 ZA ZA200103948A patent/ZA200103948B/en unknown
- 2001-06-15 NO NO20012995A patent/NO20012995L/no not_active Application Discontinuation
-
2002
- 2002-01-09 HK HK02100145.2A patent/HK1038744A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ES2226488T3 (es) | 2005-03-16 |
JP4431282B2 (ja) | 2010-03-10 |
EP1140837B1 (fr) | 2004-08-18 |
ATE273954T1 (de) | 2004-09-15 |
NZ511478A (en) | 2003-08-29 |
CN1330637A (zh) | 2002-01-09 |
PL348059A1 (en) | 2002-05-06 |
AR023727A1 (es) | 2002-09-04 |
ZA200103948B (en) | 2002-11-15 |
KR20010101258A (ko) | 2001-11-14 |
TR200101709T2 (tr) | 2001-12-21 |
CZ20012209A3 (cs) | 2001-09-12 |
DE69919580T2 (de) | 2005-09-01 |
AU3039100A (en) | 2000-07-12 |
IL142908A0 (en) | 2002-04-21 |
GB9828074D0 (en) | 1999-02-17 |
WO2000037444A1 (fr) | 2000-06-29 |
PE20001387A1 (es) | 2000-12-22 |
BR9916282A (pt) | 2001-10-02 |
CO5170533A1 (es) | 2002-06-27 |
NO20012995D0 (no) | 2001-06-15 |
AU760169B2 (en) | 2003-05-08 |
US6867192B1 (en) | 2005-03-15 |
CA2355630A1 (fr) | 2000-06-29 |
HK1038744A1 (zh) | 2002-03-28 |
HUP0104867A3 (en) | 2002-06-28 |
JP2002533326A (ja) | 2002-10-08 |
DE69919580D1 (de) | 2004-09-23 |
EP1140837A1 (fr) | 2001-10-10 |
HUP0104867A2 (hu) | 2002-04-29 |
GT199900217A (es) | 2001-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20012995L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
NO20031443L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
NO20031442D0 (no) | Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer | |
DK1028954T3 (da) | Substituerede imidazoler egnede til behandling af inflammatoriske sygdomme | |
NO20021474L (no) | Forbindelser for behandling av ischemi | |
NO20010882D0 (no) | Terapier for behandling av lungesykdommer | |
NO20014379D0 (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
NO20024005L (no) | Pteridinforbindelser for behandling av psoriasis | |
NO20026263L (no) | Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser | |
ID26102A (id) | Proses pembuatan senyawa-senyawa stilbena | |
NO20013507L (no) | Blandinger for behandling av inflammatoriske reaksjoner | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
ID26097A (id) | Proses pembuatan pakaian luar sekali pakai | |
NO20024058D0 (no) | Fremgangsmåte for fremstilling av et oksazolyletanolderivat | |
NO20003454L (no) | FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4- | |
NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
NO20005479L (no) | sPLA2-hemmende forbindelser til behandling av sykdom | |
DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
NO20033290L (no) | Pyrrolderivater for behandling av cytokinformidlede sykdommer | |
NO20012540D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
NO20012811D0 (no) | Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat | |
NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol | |
NO20020327D0 (no) | Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol | |
NO996166L (no) | FremgangsmÕte for behandling av avluter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |